Loading...
NYSE: HQL
Tekla Life Sciences Investors
Financial Services · Asset Management
Market Cap
$477.55M
52w High
$17.80
52w Low
$10.55
P/E
5.58
Volume
40.29K
Outstanding Shares
28.87M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 27.13%Revenue (TTM): -46.63%P/E: 42nd pct
What changed
The stock rose 27.13% over the last year. Revenue declined 46.63% over the trailing twelve months. Operating margin moved from -184.66% to 247.47%.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 247.47%. A decisive move in revenue — currently down 46.63% — would be the clearest signal to resolve the ambiguity.
Company profile
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC.
CEODaniel R. Omstead
SectorFinancial Services
IndustryAsset Management
Employees—
IPO dateMay 1, 1992
Valuation
Forward P/E—
EV/EBITDA5.23
Enterprise value$447.74M
Price / Book0.93
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Revenue growth-60.65%
Gross margin30.8%▲0.00%vs FY2024
Operating margin286.92%▲0.70%vs FY2024
ROE16.66%▼10.19%vs FY2024
Analyst consensus
Rating—
Target price—
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Jun 24, 2025
View
EPS
Actual vs estimate by quarter
Q3FY24
ActualEst.
$1.84
—
Q4FY24
ActualEst.
$1.22
—
Q2FY25
ActualEst.
-$1.64
—
Q3FY25
Next Est.
—
Revenue
Actual vs estimate by quarter
Q3FY24
ActualEst.
$2.07M
—
Q4FY24
ActualEst.
$1.91M
—
Q2FY25
ActualEst.
$18.2M
—
Q3FY25
Next Est.
—